MENU
TGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TG Therapeutics (TGTX) Ownership - Who owns TG Therapeutics?
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.72B
P/E Ratio
144.04
Total Cash
132.14M
Projected Growth
N/A
Total Debt
8.98M
Revenue
386.39M
Risk (Beta)
1.76
Dividend Yield
N/A
Total Cash/Share
0.83
Total Debt/Equity
0.21
Revenue/Share
2.35 USD as % of share price
Fundamentals
TGTX
Capitalization
5.72B
P/E Ratio
144.04
Risk (Beta)
1.76
Dividend Yield
N/A
Total Cash
132M
Total Cash/Share
0.83
Total Debt
8.98M
Total Debt/Equity
0.21
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.35%
Revenue
386M
ROE
N/A
Book Value
237M
P/B Ratio
24.10
Cash Flow
N/A
Earnings
0.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
156K
Current Ratio
4.02
Current Revenue Per Employee
343340.90
Dividends Per Share - Security
N/A
EBITDA
70.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
87.14
Revenue To Assets
7.60
Shares Held By Institutions
5.97B
Shares Outstanding - Current
159M
Total Liabilities
419M
Total Volume MTD
N/A
Value
-1
Gain YTD
19.635
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com